Select Committee on Innovation, Universities and Skills Written Evidence


Supplementary evidence from the Medical Research Council following the oral evidence session on 17 December 2007

  1.   Whether alternative sites outside London have been considered by the MRC since the purchase of the former National Temperance Hospital Site and if so, what form this consideration took.

  Alternative sites outside London have been considered since the purchase of the NTH site. The consideration was part of a formal options appraisal, which fed into the Outline Business Case for the UKCMRI initiative, conducted under the terms of the Treasury Green Book. The Panel selected Manchester and Cambridge as the best comparators with the BL site. The options were assessed by a Panel including an expert, external member and a member from the independent consultants (Deloittes), a process which was later approved by PA Consulting who were appointed by the MRC to carry out an independent review of the Outline Business Case.

  2.   What is the detailed breakdown of the cost to the MRC and how is this cost to be met.

  The current position is that the MRC has agreed to contribute £47m to the cost of purchasing the BL site and in addition we are planning on the basis that our contribution to the building will be of the order of £250m taking account of current estimates of inflation.

  We are planning that the MRC's contribution to the resource costs of UKCMRI will be at the current level of expenditure of NIMR in real terms—c. £38 million pa at 06-07 values.

  The above figures are of course provisional and may well change as a consequence for example of the conclusions of Paul Nurse's Scientific Planning Committee.

  The cost will be met from the Large Facilities Capital Fund (LFCF), from the sale of the NTH site, and in due course from the sale of the Mill Hill site. The current bid to the LFCF is for £118m; this is awaiting final approval from the RCUK Executive Group (RCUKEG). In the light of the changes to the availability of monies to the MRC from its Commercial Fund, we will be asking the LFCF for additional funds, though these will not be needed until the next CSR period.

  3.   A note on the timetable for negotiations with the Government over the application to the Large Facilities Capital Grant, to include what stage the MRC has currently reached, when the initial Business Plan will be agreed by the MRC Council, when it will be presented to DIUS and to the Treasury and when it is anticipated that the Treasury will make its decision.

  The Outline Business Case was approved by MRC Council in October. The Outline Business Case was also submitted to RCUK in October, and formally to DIUS in November. We are currently awaiting feedback from them. Feedback from RCUKEG consideration of the bid to the LFCF is expected in February. A final decision on the release of funding from the Large Facilities Capital Fund will depend upon the completion and review of a full Business Case to be prepared once the design work is completed.

January 2008






 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2008
Prepared 23 January 2008